Max N. Wallace - 21 Nov 2023 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
Director
Signature
/s/ Max N. Wallace by Dale A. Sander as Attorney-in-Fact
Issuer symbol
HUMA
Transactions as of
21 Nov 2023
Transactions value $
$7,811
Form type
4
Date filed
21 Nov 2023, 16:07
Previous filing
16 Jun 2023
Next filing
21 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUMA Common Stock Options Exercise $7.81K +6.56K +13.13% $1.19 56.6K 21 Nov 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HUMA Stock Options (right to buy) Options Exercise $0 -6.56K -100% $0.00* 0 21 Nov 2023 Common Stock 6.56K $1.19 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.